Encysive Pharmaceuticals Receives Written Response From FDA On Its Request for Formal Dispute Resolution for THELIN (Sitaxsentan Sodium)
September 05, 2007 18:06 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that it has received a written response from the U.S. Food and Drug Administration (FDA)...
Encysive Pharmaceuticals Announces Completion of Patient Enrollment in Phase II Diastolic Heart Failure Trial
September 04, 2007 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Sept. 4, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the Company has completed patient enrollment in the Phase II trial for Sitaxsentan sodium...
Encysive Pharmaceuticals Raises Approximately $15 Million in Equity Offering
August 20, 2007 23:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 20, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that it has entered into definitive agreements with institutional accredited investors to...
Encysive Pharmaceuticals Files Request for Formal Dispute Resolution With U.S. FDA
August 06, 2007 16:15 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that it has filed with the U.S. Food and Drug Administration (FDA) a request for formal dispute...
Encysive Pharmaceuticals Reports Second Quarter 2007 Financial Results
August 06, 2007 16:09 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Aug. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the second quarter ended June 30, 2007.
"We continue to make progress...
Encysive Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2007 Results
July 23, 2007 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 23, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will hold an investor conference call on Monday, August 6, 2007 at 4:30 p.m. ET to discuss its second quarter...
Encysive Pharmaceuticals Retains Morgan Stanley to Assist in Review of Strategic Alternatives
July 17, 2007 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 17, 2007 (PRIME NEWSWIRE) -- In connection with the matters discussed in the press release of June 15, Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced it has retained the...
Encysive Pharmaceuticals Provides Update for Thelin (Sitaxsentan Sodium)
July 13, 2007 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 13, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company and officials from the U.S. Food and Drug Administration (FDA) held a formal...
Encysive Pharmaceuticals Announces Management Change
July 09, 2007 16:06 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, July 9, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that Gordon H. Busenbark has resigned as Chief Financial Officer of the Company effective July 13,...
Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations
June 25, 2007 16:54 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, June 25, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that George W. Cole has been promoted to the position of President and Chief Executive Officer,...